Investing Profile

Kabeer Aziz

InvestorVCFounder
Partner at Adjuvant Capital
adjuvantcapital.com/team/New York, New York
Photo of Kabeer Aziz, Partner at Adjuvant Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
NYU Stern School of Business Network
66 CONNECTIONS
New York University - Leonard N. Stern School of Business Network
57 CONNECTIONS
cb
$100K - $5.0M
$1.5M
6
$300M
CompanyStageDateRound SizeTotal Raised
Minervax
Series UnknownOct 2023$57M
Series CDec 2022$23M
Series BDec 2020$58M
$140M
Co-investors: Christopher Gagliardi (Sanofi Ventures), Veronica Gambillara Fonck (Pureos Bioventures)
LimmaTech Biologics
Series AOct 2023$36M
$36M
Pulmocide
Series CDec 2022$52M
Series CMay 2021$92M
$140M
Director ChromaCode, Inc.Present
Board Observer Curevo VaccinePresent
Director PulmocidePresent
Director Frontier Nutrition, Inc.Present
Director Minervax ApSPresent
Director AN2 TherapeuticsPresent
Partner Adjuvant CapitalPresent
Director Quantoom BiosciencesPresent
Senior Associate Global Health Investment FundPresent
Associate Metalmark CapitalPresent
Analyst Greenhill & Co.Present
NYU Stern School of Business B.S. Finance & Economics
New York University - Leonard N. Stern School of Business B.S. Finance & Economics